These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 14757134)
1. Protein kinase C-beta inhibition and diabetic microangiopathy: effects on endothelial permeability responses in vitro. Idris I; Gray S; Donnelly R Eur J Pharmacol; 2004 Feb; 485(1-3):141-4. PubMed ID: 14757134 [TBL] [Abstract][Full Text] [Related]
2. Reduction of high glucose and phorbol-myristate-acetate-induced endothelial cell permeability by protein kinase C inhibitors LY379196 and hypocrellin A. Dang L; Seale JP; Qu X Biochem Pharmacol; 2004 Mar; 67(5):855-64. PubMed ID: 15104238 [TBL] [Abstract][Full Text] [Related]
3. High glucose-induced human umbilical vein endothelial cell hyperpermeability is dependent on protein kinase C activation and independent of the Ca2+-nitric oxide signalling pathway. Dang L; Seale JP; Qu X Clin Exp Pharmacol Physiol; 2005 Sep; 32(9):771-6. PubMed ID: 16173935 [TBL] [Abstract][Full Text] [Related]
4. Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation. Quagliaro L; Piconi L; Assaloni R; Martinelli L; Motz E; Ceriello A Diabetes; 2003 Nov; 52(11):2795-804. PubMed ID: 14578299 [TBL] [Abstract][Full Text] [Related]
5. Protein kinase C phosphorylates caldesmon77 and vimentin and enhances albumin permeability across cultured bovine pulmonary artery endothelial cell monolayers. Stasek JE; Patterson CE; Garcia JG J Cell Physiol; 1992 Oct; 153(1):62-75. PubMed ID: 1522136 [TBL] [Abstract][Full Text] [Related]
6. Protein kinase C beta inhibition: A novel therapeutic strategy for diabetic microangiopathy. Idris I; Donnelly R Diab Vasc Dis Res; 2006 Dec; 3(3):172-8. PubMed ID: 17160912 [TBL] [Abstract][Full Text] [Related]
7. [Protective effect of protein kinase C inhibitor Ro-31-8425 on hyperpermeability of human umbilical vein endothelial cells exposed to high glucose in vitro]. Zou M; Xue Y Nan Fang Yi Ke Da Xue Xue Bao; 2012 Dec; 32(12):1787-91. PubMed ID: 23268411 [TBL] [Abstract][Full Text] [Related]
8. Alpha-tocopherol decreases superoxide anion release in human monocytes under hyperglycemic conditions via inhibition of protein kinase C-alpha. Venugopal SK; Devaraj S; Yang T; Jialal I Diabetes; 2002 Oct; 51(10):3049-54. PubMed ID: 12351446 [TBL] [Abstract][Full Text] [Related]
9. The role of protein kinase C activation and the vascular complications of diabetes. Das Evcimen N; King GL Pharmacol Res; 2007 Jun; 55(6):498-510. PubMed ID: 17574431 [TBL] [Abstract][Full Text] [Related]
10. Involvement of PKC-beta in PTH, TNF-alpha, and IL-1 beta effects on IL-6 promoter in osteoblastic cells and on PTH-stimulated bone resorption. Radeff JM; Nagy Z; Stern PH Exp Cell Res; 2001 Aug; 268(2):179-88. PubMed ID: 11478844 [TBL] [Abstract][Full Text] [Related]
11. Bradykinin- and thrombin-induced increases in endothelial permeability occur independently of phospholipase C but require protein kinase C activation. Aschner JL; Lum H; Fletcher PW; Malik AB J Cell Physiol; 1997 Dec; 173(3):387-96. PubMed ID: 9369952 [TBL] [Abstract][Full Text] [Related]
12. Angiotensin II promotes glucose-induced activation of cardiac protein kinase C isozymes and phosphorylation of troponin I. Malhotra A; Kang BP; Cheung S; Opawumi D; Meggs LG Diabetes; 2001 Aug; 50(8):1918-26. PubMed ID: 11473056 [TBL] [Abstract][Full Text] [Related]
13. Glucose enhances human macrophage LOX-1 expression: role for LOX-1 in glucose-induced macrophage foam cell formation. Li L; Sawamura T; Renier G Circ Res; 2004 Apr; 94(7):892-901. PubMed ID: 15001526 [TBL] [Abstract][Full Text] [Related]
14. Protein kinase C betaII activation induces angiotensin converting enzyme expression in neonatal rat cardiomyocytes. Zhang Y; Bloem LJ; Yu L; Estridge TB; Iversen PW; McDonald CE; Schrementi JP; Wang X; Vlahos CJ; Wang J Cardiovasc Res; 2003 Jan; 57(1):139-46. PubMed ID: 12504823 [TBL] [Abstract][Full Text] [Related]
15. Can protein kinase C beta-selective inhibitor, ruboxistaurin, stop vascular complications in diabetic patients? He Z; King GL Diabetes Care; 2005 Nov; 28(11):2803-5. PubMed ID: 16249561 [No Abstract] [Full Text] [Related]
16. Activation of protein kinase C isoforms and its impact on diabetic complications. Geraldes P; King GL Circ Res; 2010 Apr; 106(8):1319-31. PubMed ID: 20431074 [TBL] [Abstract][Full Text] [Related]
17. Induction of endothelin-1 expression by glucose: an effect of protein kinase C activation. Park JY; Takahara N; Gabriele A; Chou E; Naruse K; Suzuma K; Yamauchi T; Ha SW; Meier M; Rhodes CJ; King GL Diabetes; 2000 Jul; 49(7):1239-48. PubMed ID: 10909984 [TBL] [Abstract][Full Text] [Related]
18. Increased endothelial albumin permeability mediated by protein kinase C activation. Lynch JJ; Ferro TJ; Blumenstock FA; Brockenauer AM; Malik AB J Clin Invest; 1990 Jun; 85(6):1991-8. PubMed ID: 2347922 [TBL] [Abstract][Full Text] [Related]
20. Role of protein kinase C isoforms in rat epididymal microvascular endothelial barrier function. Harrington EO; Brunelle JL; Shannon CJ; Kim ES; Mennella K; Rounds S Am J Respir Cell Mol Biol; 2003 May; 28(5):626-36. PubMed ID: 12707019 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]